Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-12 · accession 0001209191-23-024305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-14 | 2023-04-12 | VRTX | SACHS BRUCE I | Dir | S - Sale+OE | $326.73 | -21.3K | 59.6K | -26% | -$6.96M |
| D | 2023-04-14 | 2023-04-13 | VRTX | SACHS BRUCE I | Dir | G - Gift | $0.00 | -1,210 | 40.0K | -3% | $0 |
| D | 2023-04-14 | 2023-04-12 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $72.14 | +21.3K | 62.5K | +52% | +$1.54M |
| D | 2023-04-14 | 2023-04-12 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $0.00 | -21.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-12 | S | D | 8,026 | $327.48 | 41,210 | D | — | — | (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $327.48 (range $327.00 to $327.93). |
| 2 | Common | Common Stock | 2023-04-12 | S | D | 10,357 | $326.46 | 49,236 | D | — | — | (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $326.46 (range $326.00 to $326.97). |
| 3 | Common | Common Stock | 2023-04-12 | S | D | 2,917 | $325.65 | 59,593 | D | — | — | (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $325.65 (range $325.00 to $325.99). |
| 4 | Common | Common Stock | 2023-04-13 | G | D | 1,210 | $0.00 | 40,000 | D | — | — | |
| 5 | Common | Common Stock | 2023-04-12 | M | A | 21,300 | $72.14 | 62,510 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-04-12 | M | D | 21,300 | $0.00 | 0 | D | $72.14 · — to 2024-05-31 | 21,300 Common Stock | (F6) Fully vested |